FDA Inspection 668686 — SmithKline Beecham Pharma GmbH & co. KG
The FDA completed an inspection of SmithKline Beecham Pharma GmbH & co. KG on May 24, 2010 in Dresden. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 24, 2010
- Fiscal Year
- 2010
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Dresden (Germany)